Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens-Reference-Cited by-同舟云学术

Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens

Published:2020-12 Issue:12 Volume:56 Page:823-825
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:en
Short-container-title:Archivos de Bronconeumología

Author:

Carreras-Abad Clara,Espiau María,López-Seguer Laura,Martín-Begué Nieves,Martín-Nalda Andrea,Melendo-Pérez Susana,Mendoza-Palomar Natalia,Soler-Palacin Pere,Schaaf H. Simon,Soriano-Arandes Antoni

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference10 articles.

1. World Health Organization (WHO). Global tuberculosis report 2019. Geneva, Switzerland. 2019. Available from: https://www.who.int/tb/publications/global_report/en/ [accessed 23.04.20].

2. Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs;Huynh;Ther Adv Infect Dis,2019

3. Management of drug-resistant tuberculosis;Lange;Lancet,2019

4. World Health Organization (WHO). Multidrug-resistant tuberculosis in children and adolescents in the WHO European Region Expert opinion. 2019; Available from: http://www.euro.who.int/en/publications/abstracts/multidrug-resistant-tuberculosis-in-children-and-adolescents-in-the-who-european-region-2019 [accessed 23.04.20].

5. Update of SEPAR guideline “Diagnosis and Treatment of Drug-Resistant Tuberculosis” [published online ahead of print, 2020 May 20];Caminero;Arch Bronconeumol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cycloserine/levofloxacin;Reactions Weekly;2021-04